The First UROLIFT for Enlarged Prostate Treatment in Thailand
The First in Thailand, UROLIFT for enlarged prostate treatment
Bumrungrad International Hospital, our corporate member, is proud to introduce UroLift technology for enlarged prostate treatment, the first for Thailand. UROLIFT has now been approved by the Thai Food and Drug Administration since 5 February 2024 and is one of the standard treatments for enlarged prostate in the United States.
Enlarged prostate is a disease found in half of men over 60 years of age and 80% of men over 70. Enlarged prostate causes patients to have problems urinating such as frequent urination and incontinence, intermittency, and even urinary retention at times. These symptoms greatly affect the patient’s quality of life. There are many ways to treat enlarged prostate. Having been approved by the U.S. Food and Drug Administration (FDA) since 2013, UROLIFT is one of the standard treatments for enlarged prostate in the United States. UROLIFT has now been approved by the Thai Food and Drug Administration since 5 February 2024.
Enlarged prostate issues are common among aging men, the symptoms are such as:
- Weak flow of urine
- Straining to urinate
- Stop-start urination
- Pain or bloody urination
What is UROLIFT?
UROLIFT is a minimally invasive treatment for enlarged prostate, widening the urethra affected by the swollen prostate. Before the procedure, the patient is given mild sedation. Then a device is inserted through the urethra to access the prostate. After that 4-6, the number depending on the size and severity of the disease, tiny implants made of medical grade stainless steel and highly flexible nitinol are left in place to lift or hold the enlarged prostate tissue out of the way, opening the urethra permanently. The procedure does not require any incision or piercing into any organs and takes only 30 minutes to an hour.
Who are suitable for UROLIFT?
- Those with moderate to large prostate glands not exceeding 100 grams in size.
- Those who can still urinate or with less than 350 cc of post-void residual volume
- Those old or in poor health with risk for major surgery
- Those wishing to avoid the problem of erectile dysfunction
What are the benefits of UROLIFT treatment?
- Rapid solution to urination problems, with immediate results after surgery
- No need for a urinary catheter after surgery
- Minimally invasive
- Just mild sedation or spinal anesthesia required, no need for general anesthesia
- No sexual health effects
- No need for hospital stay
- Possible treatment for patients with high surgical risk
Learn more about Urolift procedure: https://bhx.one/Q9PzeG
Send us an enquiry today: https://bhx.one/nesbgC
About Bumrungrad International Hospital
Bumrungrad International Hospital in Asia is highly accredited. Being the first hospital in Asia to be accredited by the US-based Joint Commission International (JCI) and achieving accreditation five times since 2002. It has also obtained other notable certifications such as the DNV GL MIR Certification for Infection Risk and the Global Healthcare Accreditation with Excellence designation from GHA. Bumrungrad demonstrates high clinical success rates and low infection rates. The hospital’s laboratory is certified by the College of American Pathologists (CAP), the only one in Asia to achieve this level. Additionally, Bumrungrad is the only hospital in Thailand with an internationally-certified lab (ISO 15189) and the first hospital worldwide to achieve Certification of Conformance with GHA COVID-19 Guidelines for Medical Travel Programs. Newsweek ranked Bumrungrad as the best hospital in Thailand for two consecutive years and as one of the top 150 hospitals globally in their World’s Best Hospitals 2022 list.
For other interesting articles from our members and chamber activities, please visit our website.
